[Asparaginase, leukemia and cancer].
D000818:Animals; D001215:Asparaginase / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury; D004285:Dogs; D004342:Drug Hypersensitivity; D004926:Escherichia coli / Q000201:enzymology*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007953:Leukemia, Radiation-Induced / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012513:Sarcoma, Experimental / Q000188:drug therapy
D001215:Asparaginase
Asparaginase, leucémies et cancers.